Puma Biotechnology, Inc. (PBYI)
6.12
-0.03
(-0.49%)
USD |
NASDAQ |
Mar 20, 16:00
6.125
0.00 (0.00%)
After-Hours: 20:00
Puma Biotechnology EPS Diluted (Quarterly) : 0.2608 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Assertio Holdings, Inc. | -1.858 |
| Rigel Pharmaceuticals, Inc. | 13.54 |
| Ironwood Pharmaceuticals, Inc. | -0.014 |
| AbbVie, Inc. | 1.018 |
| Phathom Pharmaceuticals, Inc. | -0.2865 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 13.44M |
| Revenue (Quarterly) | 75.45M |
| Total Expenses (Quarterly) | 62.02M |
| Enterprise Value | 240.29M |
| Gross Profit Margin (Quarterly) | 69.35% |
| Profit Margin (Quarterly) | 17.81% |
| Earnings Yield | 9.98% |
| Operating Earnings Yield | 12.04% |
| Normalized Earnings Yield | 9.980 |